Trade

with

Bioanalytical Systems Inc
(NASDAQ: BASI)
AdChoices
=
2.20
0.00
0.00%
After Hours :
-
-
-

Open

2.31

Previous Close

2.20

Volume (Avg)

4.10k (10.83k)

Day's Range

2.16-2.31

52Wk Range

1.48-3.80

Market Cap.

17.76M

Dividend Rate ( Yield )

-

Beta

3.08

Shares Outstanding

8.07M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 22.07M

    • Net Income

    • 773.00k

    • Market Cap.

    • 17.76M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1.75

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 3.08

    • Forward P/E

    • -

    • Price/Sales

    • 0.75

    • Price/Book Value

    • 2.05

    • Price/Cash flow

    • 13.55

      • EBITDA

      • 3.16M

      • Return on Capital %

      • -1.69

      • Return on Equity %

      • -5.01

      • Return on Assets %

      • -1.69

      • Book Value/Share

      • 1.07

      • Shares Outstanding

      • 8.07M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 7.70

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -62.70

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -11.95

          • 47.82

          • Net Income

            5-Year Annual Average

          • 9.30

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 34.01

            • 42.70

            • Pre-Tax Margin

            • -1.79

            • 11.63

            • Net Profit Margin

            • -1.75

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 27.50

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -9.10

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -11.40

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.58

              • 0.62

              • Current Ratio

              • 0.71

              • 1.23

              • Quick Ratio

              • 0.47

              • 0.76

              • Interest Coverage

              • 0.25

              • 5.98

              • Leverage Ratio

              • 2.87

              • 2.16

              • Book Value/Share

              • 1.07

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -42.02

                • 31.85

                • P/E Ratio 5-Year High

                • -75.60

                • 325.07

                • P/E Ratio 5-Year Low

                • -12.35

                • 154.73

                • Price/Sales Ratio

                • 0.75

                • 2.21

                • Price/Book Value

                • 2.07

                • 2.88

                • Price/Cash Flow Ratio

                • 13.55

                • 18.15

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -5.01

                        (-27.70)

                      • 9.34

                        (9.80)

                      • Return on Assets %

                        (5-Year Average)

                      • -1.69

                        (-10.80)

                      • 4.63

                        (5.44)

                      • Return on Capital %

                        (5-Year Average)

                      • 0.94

                        (-18.70)

                      • 5.73

                        (6.77)

                      • Income/Employee

                      • -

                      • 17.17k

                      • Inventory Turnover

                      • 10.37

                      • 5.07

                      • Asset Turnover

                      • 0.97

                      • 0.48

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      830.00k
                      Operating Margin
                      3.76
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      13.55
                      Ownership

                      Institutional Ownership

                      6.79%

                      Top 10 Institutions

                      6.78%

                      Mutual Fund Ownership

                      4.37%

                      Float

                      80.75%

                      5% / Insider Ownership

                      5.26%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Extended Market Index Fund

                      •  

                        91,696

                      • 0.00

                      • 1.17

                      • Vanguard Total Stock Mkt Idx

                      •  

                        65,747

                      • 0.00

                      • 0.84

                      • DFA US Small Cap Value II Portfolio

                      •  

                        9,691

                      • 0.00

                      • 0.12

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        7,157

                      • 0.00

                      • 0.09

                      • DFA U.S. Small Cap Portfolio

                      •  

                        5,617

                      • 0.00

                      • 0.07

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        4,772

                      • 0.00

                      • 0.06

                      • Vanguard Balanced Index Fund

                      •  

                        3,300

                      • 0.00

                      • 0.04

                      • DFA U.S. Core Equity II Fund

                      •  

                        2,068

                      • 0.00

                      • 0.03

                      • DFA U.S. Vector Equity Fund

                      •  

                        1,915

                      • 0.00

                      • 0.02

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • HealthInvest Partners AB

                      •  

                        260,366

                      • +67.87%

                      • 3.22

                      • Vanguard Group, Inc.

                      •  

                        160,443

                      • +0.94%

                      • 1.99

                      • Dimensional Fund Advisors, Inc.

                      •  

                        54,038

                      • 0.00%

                      • 0.67

                      • Kessler Investment Group, LLC

                      •  

                        31,736

                      • 0.00%

                      • 0.39

                      • North Star Asset Management Inc

                      •  

                        20,000

                      • 0.00%

                      • 0.25

                      • State Street Corp

                      •  

                        11,400

                      • 0.00%

                      • 0.14

                      • Fidelity Management & Research Company

                      •  

                        4,772

                      • 0.00%

                      • 0.06

                      • UBS Securities LLC

                      •  

                        2,210

                      • +25.07%

                      • 0.03

                      • Tower Research Capital LLC

                      •  

                        1,244

                      • -28.55%

                      • 0.01

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Diagnostics & Research

                      Type

                      Slow Growth

                      Style

                      Small Value

                      Bioanalytical Systems Inc is a corporation organized in Indiana in 1974. The Company is a contract research organization providing drug discovery and development services and analytical instruments. Its clients and partners include p...moreharmaceutical, biotechnology, academic and government organizations. It supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The Companys principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic research from small start-up biotechnology companies to many of the largest global pharmaceutical companies. The drug discovery and development process is heavily regulated by the FDA and i...morets Center for Drug Evaluation and Research. It operates in two business segments contract research services and research products, both of which address the bioanalytical, preclinical, and clinical research needs of drug developers. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The services provided by its contract research services segment include Product Characterization, Method Development and Validation, Bioanalytical Testing, Stability Testing, In Vivo Pharmacology, and Preclinical and Pathology Services. The products business targets life science research and designs, develops, manufactures and markets Analytical Products, In vivo Sampling Products, Vetronics Products. It promotes its services through concentrated business development efforts, scientist-to-scientist communications and centralized corporate marketing programs. The Company competes with in-house research, development, quality control and other support service departments of pharmaceutical and biotechnology companies. Its competitors include Covance, Inc., Pharmaceutical Product Development, Inc., Charles River Laboratories, Inc., Quintiles Transnational Holdings, Inc. The Company is subject to various regulatory requirements designed to ensure the quality and integrity of its data and products.lessless

                      Key People

                      Ms. Jacqueline M. Lemke

                      Director/CEO/President

                      Dr. John B. Landis, PhD

                      Chairman of the Board/Director

                      Jeffrey Potrzebowski

                      CFO/Vice President, Divisional

                      Mr. John P. Devine, Jr

                      Vice President, Divisional

                      Mr. David L. Omachinski

                      Director

                      • Bioanalytical Systems Inc

                      • 2701 Kent Avenue

                      • West Lafayette, IN 47906

                      • USA.Map

                      • Phone: +1 765 463-4527

                      • Fax: +1 765 497-1102

                      • basinc.com

                      Incorporated

                      1974

                      Employees

                      159

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: